Goto

Collaborating Authors

 brain scan



Validation of a CT-brain analysis tool for measuring global cortical atrophy in older patient cohorts

Bal, Sukhdeep, Colbourne, Emma, Gan, Jasmine, Griffanti, Ludovica, Hanayik, Taylor, Demeyere, Nele, Davies, Jim, Pendlebury, Sarah T, Jenkinson, Mark

arXiv.org Artificial Intelligence

Quantification of brain atrophy currently requires visual rating scales which are time consuming and automated brain image analysis is warranted. We validated our automated deep learning (DL) tool measuring the Global Cerebral Atrophy (GCA) score against trained human raters, and associations with age and cognitive impairment, in representative older (>65 years) patients. CT-brain scans were obtained from patients in acute medicine (ORCHARD-EPR), acute stroke (OCS studies) and a legacy sample. Scans were divided in a 60/20/20 ratio for training, optimisation and testing. CT-images were assessed by two trained raters (rater-1=864 scans, rater-2=20 scans). Agreement between DL tool-predicted GCA scores (range 0-39) and the visual ratings was evaluated using mean absolute error (MAE) and Cohen's weighted kappa. Among 864 scans (ORCHARD-EPR=578, OCS=200, legacy scans=86), MAE between the DL tool and rater-1 GCA scores was 3.2 overall, 3.1 for ORCHARD-EPR, 3.3 for OCS and 2.6 for the legacy scans and half had DL-predicted GCA error between -2 and 2. Inter-rater agreement was Kappa=0.45 between the DL-tool and rater-1, and 0.41 between the tool and rater- 2 whereas it was lower at 0.28 for rater-1 and rater-2. There was no difference in GCA scores from the DL-tool and the two raters (one-way ANOVA, p=0.35) or in mean GCA scores between the DL-tool and rater-1 (paired t-test, t=-0.43, p=0.66), the tool and rater-2 (t=1.35, p=0.18) or between rater-1 and rater-2 (t=0.99, p=0.32). DL-tool GCA scores correlated with age and cognitive scores (both p<0.001). Our DL CT-brain analysis tool measured GCA score accurately and without user input in real-world scans acquired from older patients. Our tool will enable extraction of standardised quantitative measures of atrophy at scale for use in health data research and will act as proof-of-concept towards a point-of-care clinically approved tool.



The pandemic may have aged our brains even before we caught covid-19

New Scientist

The covid-19 pandemic may have accelerated the ageing of our brains even before we caught the infection. Research suggests that even relatively early on in the outbreak, brains aged by 5.5 months, possibly due to stress or lifestyle changes. We know that many people with long covid experience brain fog, but years after the arrival of covid-19, the pandemic's broader neurological impact is far from fully understood. To get a grasp on this, Ali-Reza Mohammadi-Nejad at Nottingham University, UK, and his colleagues trained a machine learning model on 15,000 brain scans to identify how its structure changes with age. They then fed the model pairs of brain scans from 996 volunteers from the UK Biobank study.


Your 'Eureka!' moments can be seen in brain scans

Popular Science

Breakthroughs, discoveries, and DIY tips sent every weekday. That euphoric feeling when a great idea strikes or a challenging puzzle piece fits into place is electric–and also helps our brains. Now, a team of researchers from the United States and Germany have taken a peek inside the brain to see what those so-called aha, lightbulb, or eureka moments look like. The new brain imaging shows that these flashes of insights reshape how the brain represents information and helps burn it into our memory. According to Maxi Becker, a study co-author and cognitive neuroscientist at Humboldt University in Berlin, if you have one of these aha moments when solving a problem, "you're actually more likely to remember the solution.'" The findings are detailed in a study published May 9 in the journal Nature Communications.


Revolutionary Alzheimer's Treatments Can't Help Patients Who Go Undiagnosed

WIRED

"The statistics are frightening: Dementia is the biggest killer in the UK. It has been the leading cause of death for women since 2011," says Hilary Evans, CEO of Alzheimer's Research UK and cochair of the UK Dementia Mission. "One in two of us will be affected by dementia either by caring for someone with the condition or developing it ourselves." There are reasons for optimism, however, with Alzheimer's researchers achieving extraordinary breakthroughs in the treatment of the disease. In May 2023, drugmaker Lilly announced that its new Alzheimer's drug, donanemab, slowed cognitive decline by 35 percent; in 2022, another drug, lecanemab, registered similarly promising results.


AI can tell a person's sex from brain scans with 90 per cent accuracy

New Scientist

Men's brains tend to be larger than women's, which makes them difficult to compare Are men's and women's brains all that different? A new way of investigating this question has concluded that they are – but it takes artificial intelligence (AI) to distinguish between them. The question of whether we can measure differences between men's and women's brains has long been contentious, with previous research coming up with contradictory results. One problem is that men tend to have slightly larger brains than women, probably because they generally have larger bodies, and some previous studies that compared the size of different small regions of the brain failed to adjust for the overall brain volume. However, even doing so hasn't previously resulted in clear-cut findings.


Advancing Brain Tumor Inpainting with Generative Models

Zhu, Ruizhi, Zhang, Xinru, Pang, Haowen, Xu, Chundan, Ye, Chuyang

arXiv.org Artificial Intelligence

Synthesizing healthy brain scans from diseased brain scans offers a potential solution to address the limitations of general-purpose algorithms, such as tissue segmentation and brain extraction algorithms, which may not effectively handle diseased images. We consider this a 3D inpainting task and investigate the adaptation of 2D inpainting methods to meet the requirements of 3D magnetic resonance imaging (MRI) data. Our contributions encompass potential modifications tailored to MRI-specific needs, and we conducted evaluations of multiple inpainting techniques using the BraTS2023 Inpainting datasets to assess their efficacy and limitations.


AI-Powered 'Thought Decoders' Won't Just Read Your Mind--They'll Change It

WIRED

Now, there's concern that neuroscientists might be doing the same by developing technologies capable of "decoding" our thoughts and laying bare the hidden contents of our mind. Though neural decoding has been in development for decades, it broke into popular culture earlier this year, thanks to a slew of high-profile papers. In one, researchers used data from implanted electrodes to reconstruct the Pink Floyd song participants were listening to. In another paper, published in Nature, scientists combined brain scans with AI-powered language generators (like those undergirding ChatGPT and similar tools) to translate brain activity into coherent, continuous sentences. This method didn't require invasive surgery, and yet it was able to reconstruct the meaning of a story from purely imagined, rather than spoken or heard, speech.


I love AI because it will add decades to our lives

FOX News

Fox News contributor Dr. Marc Siegel weighs in on how artificial intelligence can change the patient-doctor relationship on'America's Newsroom.' AI, ChatGPT and the like are coming for our jobs and will destroy our way of life, the doomsayers tell us. The mood is utterly different in health care, where cutting-edge physicians recognize the potential of AI to add decades to our lives and to fix the catastrophic "sick care" system, not just in the United States, but around the world. My life expectancy – and yours – is only going up, thanks to AI. Here's how and why. With the democratization of precision medicine, society will shift from a mentality that says, "I'm sick and I need treatment" to "I'm healthy and I want to stay that way." (iStock) We don't really have a health care system.